Ahmad, Zahid

Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta‐Analysis of 35 Randomized Controlled Trials

Karatasakis, A., Danek, B. A., Karacsonyi, J., Rangan, B. V., Roesle, M. K., Knickelbine, T., Miedema, M. D., Khalili, H., Ahmad, Z., Abdullah, S., et al. (2017) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 215

Statin intolerance

Ahmad, Z. (2014) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 110

Familial chylomicronemia syndrome: An expert clinical review from the National Lipid Association

Javed, F., Hegele, R. A., Garg, A., Patni, N., Gaudet, D., Williams, L., Khan, M., Li, Q., & Ahmad, Z. (2025) · Journal of Clinical Lipidology

Lipid metabolism and disordersLymphatic Disorders and Treatments

Cited by 60

The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study

Davidson, M., Stevenson, M., Hsieh, A., Ahmad, Z., Crowson, C., & Witztum, J. L. (2017) · Expert Review of Cardiovascular Therapy

Lipid metabolism and disordersLymphatic Disorders and Treatments

Cited by 54

Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1

Ahmad, Z., & Wilson, D. P. (2014) · Journal of clinical lipidology

Lipid metabolism and disordersLymphatic Disorders and Treatments

Cited by 43

Building a better understanding of the burden of disease in familial chylomicronemia syndrome

Ahmad, Z., Halter, R., & Stevenson, M. (2017) · Expert Review of Clinical Pharmacology

Lipid metabolism and disordersLymphatic Disorders and Treatments

Cited by 28